A personalized anti-cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella
E. Ylosmaki, M. Fusciello, A. Uoti, S. Feola, B. Martins, K. Aalto, F. Hamdan, J. Ciaro, T. Viitala, V. Cerullo
This paper repurposes an approved MMR vaccine in a PeptiENV platform to enhance anti-melanoma immunity and improve response to checkpoint inhibitors.
bioRxiv · Jun 7, 2021 · PreprintImmunology